Studies related to Glucagon-like Peptide 2 and Colostrum

Randomised Controlled Trial Of Colostrum To Improve Intestinal Function In Patients With Short Bowel Syndrome

Effect None
Trial Design Double blind
Trial Length 2-4 Weeks
Number of Subjects 8
Sex Both Genders
Age Range 18-29, 30-44
Body Types Underweight
Notes for this study:
In patients with short bowel syndrome, supplementation of colostrum (250mL of a beverage containing 26.5g protein; control of skim milk and protein) for four weeks failed to outperform placebo protein in improving nutritive status and protein absorption and underperformed for increasing weight and lean mass. Power output (assessed by handgrip strength) was not different between groups but increased with protein in general.

Meal-induced GLP-2 secretion was not different between groups.